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Abstract  
The present investigation was carried out to evaluate the anti-inflammatory potential of solvent extracts of Parthenium 
camphora (Family: Compositae), a non-useful and waste weed growing through waste sides. The anti-inflammatory activities 
were assessed through in vitro and in vivo procedures, the results were found to be very surprising and promising. Aqueous 
and Ethanolic solvent extracts of Parthenium camphora were found to have significant anti-inflammatory activity at doses 100 
and 120 mg/Kg during in vitro anti-inflammatory assay. The ethanolic fractions of the plant causes significant reduction in 
inflammation i.e. 92 % (120 mg/kg) followed by aqueous extract i.e. 85 % (120 mg/kg) compared to standard anti-
inflammatory drug, Diclofenac Sodium i.e. 87 % (10 mg/kg). The values of reduction in paw volume, 0.10 ± 0.05, 0.14 ± 0.05 
and 0.16 ± 0.05 were found significantly of ethanol extract, aqueous extract and Diclofenac sodium, respectively at 4 h after 
carrageenan administration. Ethanolic extracts showed potent anti-inflammatory activity in comparison to aqueous extracts. 
The extracts showed higher anti-inflammatory potential as the dose varies. Thus results showed that extracts showed 
significant anti-inflammatory activity in dose-dependent manner. The extracts exhibited membrane stabilization effect by 
inhibiting hypotonicity induced lysis of erythrocyte membrane. The erythrocyte membrane is analogous to the lysosomal 
membrane, and its stabilization implies that the extract may as well stabilize lysosomal membrane. Stabilization of lysosomal 
membrane is important in limiting the inflammatory response by preventing the release of lysosomal constituents of activated 
neutrophils such as bacterial enzymes and proteases which cause further tissue inflammation and damage. From the above 
study it was concluded that the ethanolic extract of Parthenium camphora has significant membrane stabilization property 
compared to the aqueous extract of the same plant and it was comparable to the standard drug Diclofenac Sodium. 
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INTRODUCTION 
 
     Medicinal plants will continue to provide a source for 
generating novel drug compounds. Plants may become the base for 
the development of a new medicine or they may be used as phyto 
medicine for the treatment of disease [1]. It is estimated that plant 
materials are present in, or have provided the models for 50% 
Western drugs [2]. The primary benefit of using plant-derived 
medicine is that they are relatively safer than synthetic alternatives, 
offering profound therapeutic benefits and more affordable 
treatments [3]. Many plants have proved to successfully aid in 
various ailments leading to mass screening for their therapeutic 
components. Today, the search for natural compounds rich in 
antimicrobial, antioxidant and anti-inflammatory properties is 
escalating due to their medicinal importance in controlling many 
related chronic disorders (cancer, diabetes, arthritis, hypertension 
etc). Ant-inflammatory activities and active principles from plants of 
North West Himalaya Garhwal region were determined [4-8]. Natural 
products derived from plants offer a new source of biological that 
may have a great impact overall human health [9]. Typical 
inflammatory diseases such as rheumatoid arthiritis, asthma, colitis 
and hepatitis are among the causes of death and disability in the 
world [10-12]. Inflammation is a normal protective response to tissue 
injury that is caused by physical trauma, noxious chemicals or 
microbiological agents. Inflammation is the result of concerted 
participation of a large number of vasoactive, chemotactic and 
proliferative factors at different stages and there are many targets for 
anti inflammatory action [13]. Inflammatory response is a series of 
well coordinated dynamic mechanism consisting of  specific 
vascular, humoral and cellular events that is characterized by the 
movement of fluids, plasma and inflammatory leukocytes 
(neutrophils, eosinophils, basophils and macrophages) to the site of 
inflammation [14, 15]. A variety of chemical mediators or signaling 
molecules such as histamine, serotonin, leukotrienes, prostaglandins 
and oxygen derived free radicals (O2, OH, ONOO-) are produced by 
inflammatory and phagocytic cells predominantly in the sequences 
which participates in onset of inflammation [16, 17]. In the present 
investigation we have reported the in vitro and in vivo anti-
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inflammatory activities of different solvent extracts of whole plant of P. 
camphora.  
 
MATERIALS AND METHODS 
 
     The chemicals and reagents used were of Analytical Grade 
and were procured from Ranbaxy and CDH. The animal house used 
was ethical committee approved in HIHT University, Dehradun (U.K), 
India.  
 
Collection of Plant material  
 
     The whole plant, Parthenium camphora belonging to 
Compositae family was selected for the study. The herbariums of 
plant material were prepared and were further identified by Dr. Ajai 
Swami, Chinmaya Degree College, Haridwar (U.K), India. Whole 
plant material of Parthenium was dried under shade and ground to 
form the fine powder. 
 
Preparation of Solvent Extracts 
 
     The powdered plant material was soaked in approximately 
400 ml of ethanol and water separately on an electrical shaker for 
three hours at room temperature and then left to stand overnight. 
The mixtures were filtered into conical flasks using Whatmann filter 
paper No. 1. The filtrate was then concentrated on a rotary 
evaporator at 50oC to yield semi-solid masses whose weights were 
determined. The extracts were then stored in a refrigerator at 40C. 
The extracts doses were optimized by determination of LD50 of the 
dose. The dose at which death of the 50 % of the animal population 
in the group occurs is known as LD50. 
 
In vitro studies for determination of anti-inflammatory potential 
(A) The human red blood cell (HRBC) membrane stabilization 
method 
     The method as prescribed [18, 19] was adopted with some 
modifications  The blood was collected from healthy human 
volunteer who had not taken any NSAIDS for 2 weeks prior to the 
experiment and mixed with equal volume of Alsever solution (2 % 
dextrose, 0.8 % sodium citrate, 0.5 % citric acid and 0.42 % NaCl) 
and centrifuged at 3,000 rpm. The packed cells were washed with 
isosaline and a 10 % suspension was made. Various concentrations 
of extracts were prepared (100 and 120 mg/ml) using distilled water 
and to each concentrations, 1 ml of phosphate buffer, 2 ml hypo 
saline and 0.5 ml of HRBC suspension were added. It was incubated 
at 370C for 30 minutes and centrifuged at 3,000 rpm for 20 minutes 
and the hemoglobin content of the supernatant solution was 
estimated spectrophotometrically at 560 nm. Diclofenac (100 µg/ml) 
was used as reference standard and a control was prepared by 
omitting the extracts. The experiments were performed in triplicates 
and mean values of the three were considered. The percentage (%) 
of HRBC membrane stabilization or protection was calculated using 
the following formula:  
Percent Protection (%) = (100- OD of drug treated sample/OD of 
Control) X 100 
(B) Inhibition of Albumen Denaturation 
 
     Method as prescribed [19] was followed with minor 
modifications. The reaction mixture was consisting of test extracts 
and 1% aqueous solution of bovine albumin fraction, pH of the 
reaction mixture was adjusted using small amount at 37°C HCl. The 
sample extracts were incubated at 37°C for 20 minutes and then 
heated to 51°C for 20 minutes after cooling the samples the turbidity 
was measured spectrophotometrically at 660 nm. Diclofenac sodium 
was taken as a standard drug. The experiment was performed in 
triplicates. Percent inhibition of protein denaturation was calculated 
as follows:  
 
Percent inhibition (%) = (OD of Control-OD of Sample/OD of Control) 
X100 
(C) Heat induced hemolysis 
 
     The reaction mixture (2 ml) consisted of 1 ml of test sample 
solution and 1 ml of 10 % RBCs suspension, instead of test sample 
only saline was added to the control test tube. Diclofenac sodium 
was taken as a standard drug. All the centrifuge tubes containing 
reaction mixture were incubated in water bath at 56°C for 30 minutes. 
At the end of the incubation the tubes were cooled under running tap 
water. The reaction mixture was centrifuged at 2500 rpm for 5 
minutes and the absorbance of the supernatants was taken at 560 
nm. The experiment was performed in triplicates for all the test 
samples. Percent hemolysis was calculated by the formula 
mentioned in the above procedure.  
 
In vivo studies for determination of anti-inflammatory potential 
Animals 
 
     Extracts of whole plant of Parthenium camphora were 
evaluated. Male albino rats (180–200 g) were used taking into 
account international principles and local regulations concerning the 
care and use of laboratory animals [20]. The animals had free 
access to a standard commercial diet and water ad libitum and were 
kept in rooms maintained at 22 ± 1ºC with a 12 h light/dark cycle. 
The in vivo anti-inflammatory activity was performed in HIHT 
University, Dehradun (U.K), India. The institutional animal ethical 
committee has approved the protocol of the study. 
 
Carrageenan-induced edema in rats 
 
     For screening in vivo anti-inflammatory activity for each of the 
extracts, 5 Groups of five animals each were used.  
 
Group I: Treatment with Vehicle/Control (Distilled water); 10 ml/Kg 
Group II: Treatment with Vehicle/Control (Ethanol); 10 ml/Kg 
Group III: Treatment with Ethanolic extract of whole plant of P. 
camphora (Test); 100 & 120 mg/Kg 
Group IV: Treatment with Aqueous extract of whole plant of P. 
camphora (Test); 100 & 120 mg/Kg 
Group V: Treatment with Standard drug, Diclofenac Sodium (10 
mg/Kg)  
 
     Paw swelling was induced by sub-plantar injection of 0.1 ml 
1% sterile carrageenan in saline into the right hind paw. The solvent 
extracts of plant at dose of 100 and 120 mg/kg were administered 
orally 60 minutes before carrageenan injection. Diclofenac Sodium 
(10 mg/kg) was used as reference drug. Control group received the 
vehicle only (10 ml/kg). The inflammation was quantified by 
measuring the volume displaced by the paw, using a 
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plethysmometer at time 0, 1, 2, 3, and 4 h after carrageenan injection. 
The difference between the left and the right paw volumes (indicating 
the degree of inflammation) was determined and the percent 
inhibition of edema was calculated in comparison to the control 
animals. 
 
RESULTS 
 
     Aqueous and Ethanolic solvent extracts of Parthenium 
camphora were found to have significant anti-inflammatory activity at 
doses 100 and 120 mg/Kg during in vitro anti-inflammatory assay. 
During in vivo anti-inflammatory activity, the paw edema was 
reduced significantly in carrageenan induced albino rats through 
introduction of ethanolic extracts at a dosage 120 mg/Kg. Ethanolic 
extracts showed potent anti-inflammatory activity in comparison to 
aqueous extracts. The extracts showed higher anti-inflammatory 
potential as the dose varies. Thus results showed that extracts 
showed significant anti-inflammatory activity in dose-dependent 
manner. 
 
Table 1. Percent activity of HRBC membrane stabilization 
 
S.No. Groups Concentration of Extracts of 
Parthenium camphora 
Percent Protection± SD 
I Control 100 mg/ml - 
120 mg/ml - 
II Ethanolic extract 100 mg/ml 56.2 ±0.06 
*120 mg/ml 72.5 ±0.06 
III 
 
Aqueous extract 100 mg/ml 46.5 ±0.06 
*120 mg/ml 68.2 ±0.06 
 
IV 
Standard 
(Diclofenac Sodium) 
100 mg/ml 72.34 ±0.06 
*120 mg/ml 83.54 ±0.06 
                    *Potent Extracts/Drug 
 
 
 
Fig 1. HRBC (Human Red Blood Cell) Membrane Stabilization Assay 
 
Table 2. Percent Inhibition of Albumen Denaturation 
 
S.No. Groups Concentration of Extracts of 
Parthenium camphora 
Percent Protection± SD 
I Control 100 mg/ml - 
120 mg/ml - 
II Ethanolic extract 100 mg/ml 76.2 ±0.06 
*120 mg/ml 89.61±0.06 
III 
 
Aqueous extract 100 mg/ml 72.5 ±0.06 
*120 mg/ml 86.81±0.06 
 
IV 
 
Standard 
(Diclofenac Sodium) 
100 mg/ml 78.54 ±0.06 
*120 mg/ml 93.54 ±0.06 
                    *Potent Extracts/Drug 
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Fig 2. Percent Inhibition of Albumen Denaturation 
 
Table 3. Percent Inhibition of Heat Induced Hemolysis 
 
S.No. Groups Concentration of Extracts of 
Parthenium camphora 
Percent Protection± SD 
I Control 100 mg/ml - 
120 mg/ml - 
II Ethanolic extract 100 mg/ml 56.2 ±0.06 
*120 mg/ml 78.82±0.06 
III 
 
Aqueous extract 100 mg/ml 42.5 ±0.06 
*120 mg/ml 76.65±0.05 
 
IV 
Standard 
(Diclofenac Sodium) 
100 mg/ml 78.54 ±0.06 
*120 mg/ml 85.92 ±0.05 
                      *Potent Extracts/Drug 
 
Fig 3. Percent Inhibition of Heat Induced Hemolysis  
Carrageenan-induced edema in rats 
 
Table 4: Anti-inflammatory activities of different extracts of Parthenium camphora 
 
                                                                                         Paw volume (ml) ± SD 
Experiment Control Diclofenac Sodium 
(10 mg/kg orally) 
Ethanol extract 
(120 mg/kg) 
Aqueous extract 
(120 mg/kg) 
Ethanol 
(120 ml/kg) 
Distilled water 
(120 ml/kg) 
1h after treatment 0.25±0.05 0.21±0.05 0.23± 0.05 0.28±0.003 0.20±0.05 0.34±0.05 
2h after treatment 0.25±0.05 0.18±0.05 0.20± 0.05 0.24±0.05 0.15±0.05 0.34±0.05 
4h after treatment 0.25±0.05 0.16±0.05 0.10± 0.05 0.14±0.05 0.30±0.05 0.34±0.05 
±, S.D, Standard Deviation 
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Fig 4. Reduction in paw volume (volume of water displaced) by treatment of different extracts of Parthenium camphora and treatment of positive and negative controls. 
 
In vitro studies for determination of anti-inflammatory potential 
(A) The human red blood cell (HRBC) membrane stabilization 
method:  
     Amongst aqueous and ethanolic extracts, the ethanolic 
extracts at a concentration of 120 mg/ml showed 72.5 ±0.06 % 
protection of HRBC in hypotonic solution in comparison to aqueous 
extracts (68.2 ±0.06 %). The results were compared with standard 
Diclofenac Sodium which showed 83.54 ±0.06 % protections at 120 
mg/ml. The results are shown in Table 1 and Figure 1.  Parthenium 
camphora whole plant extracts exhibited membrane stabilization 
effect by inhibiting hypotonicity induced lysis of erythrocyte 
membrane. The erythrocyte membrane is analogous to the 
lysosomal membrane [21] and its stabilization implies that the extract 
may as well stabilize lysosomal membranes. Stabilization of 
lysosomal membrane is important in limiting the inflammatory 
response by preventing the release of lysosomal constituents of 
activated neutrophil such as bactericidal enzymes and proteases, 
which cause further tissue inflammation and damage upon extra 
cellular release [22]. Some of the NSAIDs are known to posses 
membrane stabilization properties which may contribute to the 
potency of their anti-inflammatory effect. Though the exact 
mechanism of the membrane stabilization by the extract is not known 
yet; hypotonicity-induced hemolysis may arise from shrinkage of the 
cells due to osmotic loss of intracellular electrolyte and fluid 
components. The extract may inhibit the processes, which may 
stimulate or enhance the efflux of these intracellular components [23]. 
(B) Inhibition of Albumen Denaturation:  
 
     Denaturation of proteins is a well documented cause of 
inflammation. As part of the investigation on the mechanism of the 
anti inflammation activity, ability of extract protein denaturation was 
studied. The ethanolic extracts were found to be effective in inhibiting 
heat induced albumin denaturation in comparison to aqueous 
extracts at a dose of 120 mg/ml. Maximum inhibition 89.61±0.06 was 
observed from ethanolic extracts followed by aqueous extracts 
(86.81±0.06). The results were compared with standard Diclofenac 
Sodium which showed 93.54 ±0.06 % inhibition in albumen 
denaturation at 120 mg/ml. The results are reported in Table 2 and 
Figure 2. Since during inflammation condition, protein of the cell gets 
denatured, thus here albumen protein is used as a model whose 
protection in denaturation by plant extracts was studied.  
 
(C) Heat induced hemolysis:  
 
     Stabilization of RBCs membrane was studied for further 
establishes the mechanism of anti-inflammatory action of different 
water extract of Parthenium camphora. Both  the extracts were 
effectively inhibiting the heat induced hemolysis. These results 
provide evidence for membrane stabilization as an additional 
mechanism of their anti-inflammatory effect. This effect may possibly 
inhibit the release of lysosomal content of neutrophils at the site of 
inflammation. The extracts inhibited the heat induced hemolysis of 
RBCs to varying degree.  The maximum inhibition was recorded 
78.82±0.06 % from ethanolic extract followed by aqueous extracts 
(76.65±0.05 %). The results were compared with standard 
Diclofenac Sodium which showed the maximum inhibition 85.92 
±0.05 % at 120 mg/ml. The results are reported in Table 3 and 
Figure 3. Heat induced hemolysis method is another method 
depicting HRBC membrane stabilization.  
 
In vivo studies for determination of anti-inflammatory potential 
Carrageenan-induced edema in rats 
 
     The anti-inflammatory effects of the solvent extracts of 
Parthenium camphora on carrageenan-induced edema in rat’s hind 
paws are presented in Table 4 and Figure 4. The anti-inflammatory 
activities of extracts were found to have effect in dose-dependent 
manner.  There was a gradual increase in edema paw volume of 
rats in the control group. However, in the test groups, ethanolic 
extract and aqueous extract (120 mg/kg) showed a significant 
reduction in the edema paw volume. There was no reduction in 
inflammation found in case of rats treated with ethanol and distilled 
water. The results showed that ethanolic fractions of the plant 
causes significant reduction in inflammation i.e. 92 % (120 mg/kg) 
followed by aqueous extract i.e. 85 % (120 mg/kg) compared to 
standard anti-inflammatory drug, Diclofenac Sodium i.e. 87 % (10 
mg/kg). The values of reduction in paw volume, 0.10 ± 0.05, 0.14 ± 
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0.05 and 0.16 ± 0.05 were found significantly of ethanol extract, 
aqueous extract and Diclofenac sodium, respectively at 4 h after 
carrageenan administration. 
 
DISCUSSION 
 
     In the present investigation carried out to evaluate the anti-
inflammatory potential of solvent extracts of Parthenium camphora 
(Family: Compositae) through in vitro and in vivo procedures, the 
results were found to be very surprising and promising. Parthenium 
is a waste plant and a weed growing randomly in fields and at the 
road sides. The pollen grains dispersal through air and other sources 
can leads to its uncontrolled growth. One cannot imagine its potential 
pharmacological properties. The previous studies reported its 
pharmacological properties and anti-inflammatory behavior [24-27]. 
The extracts exhibited membrane stabilization effect by inhibiting 
hypotonicity induced lysis of erythrocyte membrane. The erythrocyte 
membrane is analogous to the lysosomal membrane [21] and its 
stabilization implies that the extract may as well stabilize lysosomal 
membrane. Stabilization of lysosomal membrane is important in 
limiting the inflammatory response by preventing the release of 
lysosomal constituents of activated neutrophil such as bacterial 
enzymes and proteases which cause further tissue inflammation and 
damage [22]. From the above study it was concluded that the 
ethanolic extract of Parthenium camphora has significant membrane 
stabilization property compared to the aqueous extract of the same 
plant and it was comparable to the standard drug Diclofenac Sodium. 
Denaturation of proteins is a well documented cause of inflammation. 
The inflammatory drugs (salicylic acid, phenylbutazone etc) have 
shown dose dependent ability to thermally induced protein 
denaturation. Similar results were observed from many reports from 
plant extract [19]. From the above study it was concluded that the 
ethanolic extract of Parthenium camphora had maximum albumen 
denaturation protection property as compared to the aqueous extract 
of the same plant and it was comparable to the standard drug 
Diclofenac Sodium. The extracts may possibly inhibit the release of 
lysosomal content of neutrophils at the site of inflammation. The 
precise mechanism of this membrane stabilization is yet to be 
elucidated; it is possible that the Parthenium camphora produced this 
effect by reducing the surface area/volume ratio of the cells, which 
could be brought about by an expansion of membrane or the 
shrinkage of cells and an interaction with membrane proteins. The 
above findings also confirmed that ethanolic extracts of Parthenium 
camphora possessed maximum protection activity of RBC 
membrane by heat induction in comparison to aqueous extracts. This 
can be due to the reduction in heat induced by inflammation 
(associated with any disease) by the effect of plant extracts.  When 
the extracts were evaluated for in vivo anti-inflammatory activity on 
carrageenan induced albino rats, the ethanolic and aqueous extracts 
also showed the similar pattern as that of in vitro studies. Amongst 
the extracts, ethanolic extracts at 120 mg/Kg showed maximum 
reduction in paw edema in comparison to aqueous extracts. The 
ethanolic fractions of the plant causes significant reduction in 
inflammation i.e. 92 % (120 mg/kg) followed by aqueous extract i.e. 
85 % (120 mg/kg) compared to standard anti-inflammatory drug, 
Diclofenac Sodium i.e. 87 % (10 mg/kg). The values of reduction in 
paw volume, 0.10 ± 0.05, 0.14 ± 0.05 and 0.16 ± 0.05 were found 
significantly of ethanol extract, aqueous extract and Diclofenac 
sodium, respectively at 4 h after carrageenan administration. The 
studies thus confirmed that Parthenium camphora is a potent anti-
inflammatory agent. The findings of the study corelate the previous 
studies reported [24, 25, 27]. Further studies in future context on the 
basis of present studies are however needed to isolate the active 
principle (s) responsible for anti-inflammatory potential. 
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